Saudi Arabia Osteoporosis Drugs Market Outlook Industry Share, Growth, Drivers, Emerging Technologies, and Forecast Research Report 2029
Data Bridge Market Research analyses that the Saudi Arabia osteoporosis drugs market will grow at a CAGR of 2.9% during the forecast period of 2022 to 2029. The different types of medications for osteoporosis are available in the market. The bisphosphonates are usually the first choice for treatment of osteoporosis. These includes Risedronate (Actonel), a weekly or monthly pill, Alendronate (Fosamax), a weekly pill, Zoledronic acid (Reclast), an annual IV infusion and Ibandronate (Boniva), a monthly pill or quarterly intravenous (IV) infusion.
Comments
Post a Comment